1990
DOI: 10.1016/0014-2999(90)90087-m
|View full text |Cite
|
Sign up to set email alerts
|

The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
20
0
2

Year Published

1991
1991
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 5 publications
1
20
0
2
Order By: Relevance
“…At 91 days of age the offspring were transported to the Janssen Research Foundation (Beerse, Belgium). After 1 week of acclimatisation (at 98 days of age) the measurement of blood pressure and heart rate was carried out as described previously [14]. Briefly, the animals were anaesthetised with ether and a femoral artery and vein dissected free of surrounding tissue and cannulated.…”
Section: Methodsmentioning
confidence: 99%
“…At 91 days of age the offspring were transported to the Janssen Research Foundation (Beerse, Belgium). After 1 week of acclimatisation (at 98 days of age) the measurement of blood pressure and heart rate was carried out as described previously [14]. Briefly, the animals were anaesthetised with ether and a femoral artery and vein dissected free of surrounding tissue and cannulated.…”
Section: Methodsmentioning
confidence: 99%
“…The SRRR-enantiomer (d-nebivolol) is a potent and cardioselective _1-adrenergic blocker. The RSSS-enantiomer (l-nebivolol) has a favourable hemodynamic profile, in that normal energy supply during exercise is nor affected [3].…”
Section: Introductionmentioning
confidence: 99%
“…Nebivolol is a new b-blocker with highly selective b 1 -adrenergic receptor blocking and direct vasodilatory properties [9]. The mechanism of vasodilatation is attributed to the generation of NO, an effect that can be inhibited by N G -monomethyl-L-arginine [10].…”
Section: Introductionmentioning
confidence: 99%